🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
B-cell Lymphoma is an aggressive and rare cancer of a type of immune cell (...
Status
Active Not Recruiting
Location
The University of Arizona Cancer Center - North Campus /ID# 242219
Start Date
2022-06-14
Trial ID
NCT05283720
Acute Myeloid Leukemia (AML) is an aggressive and rare cancer of myeloid ce...
Status
Completed
Location
Pusan National University Hospital /ID# 239010
Start Date
2021-04-05
Trial ID
NCT04826523
Acute Myeloid Leukaemia (AML) is an aggressive and rare cancer of myeloid c...
Status
Active Not Recruiting
Location
City of Hope /ID# 154105
Start Date
2017-02-02
Trial ID
NCT02993523
Treatments Being Tested
The purpose of this research study is to test the safety and efficacy of a ...
Status
Recruiting
Location
Brigham and Women's Hospital
Start Date
2026-02-02
Trial ID
NCT07148180
Treatments Being Tested
This is a Phase 1b, open-label study evaluating Venetoclax in combination w...
Status
Recruiting
Location
Montefiore Einstein Cancer Center and Children's Hospital at Montefiore (CHAM)
Start Date
2022-05-25
Trial ID
NCT05342584
Treatments Being Tested
Mantle Cell Lymphoma (MCL) is a form of Non-Hodgkin Lymphoma (NHL - cancer ...
Status
Completed
Location
NHO Nagoya Medical Center /ID# 221958
Start Date
2020-09-23
Trial ID
NCT04477486
Treatments Being Tested
The goal of this study is to assess the safety, tolerability, efficacy, pha...
Status
Recruiting
Location
Centre Hospitalier Universitaire Grenoble Alpes
Start Date
2024-01-05
Trial ID
NCT06191263
Treatments Being Tested
A study evaluating the effectiveness and safety of venetoclax, in combinati...
Status
Completed
Location
Arizona Oncology Associates, PC-HOPE /ID# 211509
Start Date
2019-08-15
Trial ID
NCT03941964
Treatments Being Tested
Acute Myeloid Leukemia (AML) is an aggressive and rare cancer of myeloid ce...
Status
Completed
Location
Anjou Kousei Hospital /ID# 244213
Start Date
2021-05-28
Trial ID
NCT04813263
The main aim is to see how the combination of pevonedistat + venetoclax + a...
Status
Completed
Location
Banner MD Anderson Cancer Center
Start Date
2020-10-13
Trial ID
NCT04266795
Treatments Being Tested